MAP2K1 and Miyoshi myopathy: PD-L1 expression on MM cells is enhanced following stimulation of IFNγ via activation of MYD88, TRAF6, and MEK/ERK signaling pathways; conversely, MEK1/2 inhibitors partially block IFNγ-induced PD-L1 upregulation (20, 133).